发布求助
文献互助 智能选刊 最新文献

European Journal of Cancer最新文献

筛选
英文 中文
A-168 International study of Sezary Syndrome reveals improved disease-specific survival from modern systemic therapies A-168 对塞扎里综合征的国际研究显示，现代系统疗法提高了疾病特异性生存率
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114391
B.A. Campbell, G. Dobos, Z. Haider, M. Bagot, F. Evison, C. van der Weyden, C. McCormack, C. Ram-Wolff, M. Miladi, M. Prince, J. Scarisbrick
{"title":"A-168 International study of Sezary Syndrome reveals improved disease-specific survival from modern systemic therapies","authors":"B.A. Campbell, G. Dobos, Z. Haider, M. Bagot, F. Evison, C. van der Weyden, C. McCormack, C. Ram-Wolff, M. Miladi, M. Prince, J. Scarisbrick","doi":"10.1016/j.ejca.2024.114391","DOIUrl":"10.1016/j.ejca.2024.114391","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114391"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-120 Radiotherapy of Cutaneous Lymphomas: Real-world Pattern-of-Care Analysis Among EORTC Members A-120 皮肤淋巴瘤的放射治疗：EORTC 成员的真实世界护理模式分析
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114404
K. Elsayad, E. Guenova, B. Fournier, C. Fernandes, R. Cowan, D. Correia, Cutaneous Lymphoma Tumour Group
{"title":"A-120 Radiotherapy of Cutaneous Lymphomas: Real-world Pattern-of-Care Analysis Among EORTC Members","authors":"K. Elsayad, E. Guenova, B. Fournier, C. Fernandes, R. Cowan, D. Correia, Cutaneous Lymphoma Tumour Group","doi":"10.1016/j.ejca.2024.114404","DOIUrl":"10.1016/j.ejca.2024.114404","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114404"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-154 Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management A-154 皮肤T细胞淋巴瘤治疗中可能出现的莫干单抗相关炎症性肠病
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114401
G. Blanchard, M. Blanchard, P. Bernard, J. Doms, B. Cortés, S. Boulinguez, E. Guenova
{"title":"A-154 Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management","authors":"G. Blanchard, M. Blanchard, P. Bernard, J. Doms, B. Cortés, S. Boulinguez, E. Guenova","doi":"10.1016/j.ejca.2024.114401","DOIUrl":"10.1016/j.ejca.2024.114401","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114401"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-162 Identifying Patients With Poor Outcomes in Mycosis Fungoides & Sezary syndrome For Improved Management Choices A-162 识别真菌病和塞扎里综合征疗效不佳的患者以改进治疗选择
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114389
J. Scarisbrick, Y. Kim
{"title":"A-162 Identifying Patients With Poor Outcomes in Mycosis Fungoides & Sezary syndrome For Improved Management Choices","authors":"J. Scarisbrick, Y. Kim","doi":"10.1016/j.ejca.2024.114389","DOIUrl":"10.1016/j.ejca.2024.114389","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114389"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-298 RESMAIN: Results of a multicenter, randomized, double blind, placebo-controlled trial to evaluate RESminostat for MAINtenance treatment in advanced stage Mycosis fungoides or Sézary syndrome A-298 RESMAIN：一项多中心、随机、双盲、安慰剂对照试验的结果，以评估 RESminostat 用于晚期真菌病或塞扎里综合征 MAIN 维护治疗的效果
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114406
R. Stadler, S. Woei-A-Jin, R. Dummer, C. Mitteldorf, E. Papadavid, P. Quaglino, P. Ortiz, E. Guenova, R. Abe, A.M. Busschots, J. Scarisbrick
{"title":"A-298 RESMAIN: Results of a multicenter, randomized, double blind, placebo-controlled trial to evaluate RESminostat for MAINtenance treatment in advanced stage Mycosis fungoides or Sézary syndrome","authors":"R. Stadler, S. Woei-A-Jin, R. Dummer, C. Mitteldorf, E. Papadavid, P. Quaglino, P. Ortiz, E. Guenova, R. Abe, A.M. Busschots, J. Scarisbrick","doi":"10.1016/j.ejca.2024.114406","DOIUrl":"10.1016/j.ejca.2024.114406","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114406"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-198 Real-world effectiveness of mogamulizumab in Spain and Portugal: Second interim analysis of the MIBERIC study A-198 莫干珠单抗在西班牙和葡萄牙的实际疗效：MIBERIC研究的第二次中期分析
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114405
P.O. Romero, R.M. Pujol, M. Cravo, C.M. Montserrat, I.Q. Cuba, D.N. Rodríguez, P. Fernández-Caldas González, M.A. Cortés, A. Combalia, R.M. Rodríguez Núñez, R. Córdoba, R. Cabral, A. Núñez, I. Zeberio, R. Fernández-de-Misa, M.L. Velasco, E.M. Feijoo, X. Martín-Martitegui, F.J. Capote, J.F. Millán Cayetano, A.M. Villar
{"title":"A-198 Real-world effectiveness of mogamulizumab in Spain and Portugal: Second interim analysis of the MIBERIC study","authors":"P.O. Romero, R.M. Pujol, M. Cravo, C.M. Montserrat, I.Q. Cuba, D.N. Rodríguez, P. Fernández-Caldas González, M.A. Cortés, A. Combalia, R.M. Rodríguez Núñez, R. Córdoba, R. Cabral, A. Núñez, I. Zeberio, R. Fernández-de-Misa, M.L. Velasco, E.M. Feijoo, X. Martín-Martitegui, F.J. Capote, J.F. Millán Cayetano, A.M. Villar","doi":"10.1016/j.ejca.2024.114405","DOIUrl":"10.1016/j.ejca.2024.114405","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114405"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A-238 Increased mortality due to lymphoma and infections in patients with mycosis fungoides and Sézary syndrome: A Swedish nationwide, population-based cohort study A-238 真菌病和塞扎里综合征患者因淋巴瘤和感染导致的死亡率增加：一项瑞典全国性人群队列研究
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114421
L.U. Ivert, S. Ekberg, K.E. Smedby, H. Brauner
{"title":"A-238 Increased mortality due to lymphoma and infections in patients with mycosis fungoides and Sézary syndrome: A Swedish nationwide, population-based cohort study","authors":"L.U. Ivert, S. Ekberg, K.E. Smedby, H. Brauner","doi":"10.1016/j.ejca.2024.114421","DOIUrl":"10.1016/j.ejca.2024.114421","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114421"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142417454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
32 (PB020): Discovery of novel MTA-cooperative PRMT5 inhibitors as targeted therapeutics for MTAP-deleted cancers 32 (PB020)：发现新型 MTA 协作 PRMT5 抑制剂，作为 MTAP 缺失型癌症的靶向治疗药物
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114560
A. Radzimierski, A. Bobowska, A. Stachowicz, K. Kuś, K. Kozłowska-Tomczyk, A. Ludwig-Słomczyńska, A. Gołas, M. Żukowska, G. Ćwiertnia, K. Brzózka, M. Nowak, A. Bartosik, D. Pez
{"title":"32 (PB020): Discovery of novel MTA-cooperative PRMT5 inhibitors as targeted therapeutics for MTAP-deleted cancers","authors":"A. Radzimierski, A. Bobowska, A. Stachowicz, K. Kuś, K. Kozłowska-Tomczyk, A. Ludwig-Słomczyńska, A. Gołas, M. Żukowska, G. Ćwiertnia, K. Brzózka, M. Nowak, A. Bartosik, D. Pez","doi":"10.1016/j.ejca.2024.114560","DOIUrl":"10.1016/j.ejca.2024.114560","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114560"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
99 (PB087): Discovery and characterization of BRD4 degraders utilizing diverse E3 ligases for treatment of acute myeloid leukemia (AML). 99 (PB087)：利用多种 E3 连接酶发现和鉴定用于治疗急性髓性白血病 (AML) 的 BRD4 降解剂。
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114623
M. Hamada, S. Ooike, K. Ohba, Y. Niwa, Y. Togashi, H. Maruyama, T. Matsudaira, T. Hosoi, M. Tokura, R. Fujita, M. Tanaka
{"title":"99 (PB087): Discovery and characterization of BRD4 degraders utilizing diverse E3 ligases for treatment of acute myeloid leukemia (AML).","authors":"M. Hamada, S. Ooike, K. Ohba, Y. Niwa, Y. Togashi, H. Maruyama, T. Matsudaira, T. Hosoi, M. Tokura, R. Fujita, M. Tanaka","doi":"10.1016/j.ejca.2024.114623","DOIUrl":"10.1016/j.ejca.2024.114623","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114623"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
41 (PB029): Preclinical characterization of ABSK131, a potential best-in-class MTAcooperative PRMT5 inhibitor 41（PB029）：潜在的同类最佳 MTA 合作 PRMT5 抑制剂 ABSK131 的临床前表征
IF 7.6 1区 医学
European Journal of Cancer Pub Date : 2024-10-01 DOI: 10.1016/j.ejca.2024.114569
W. Pan, H. Wang, F. Qi, H. Deng, H. Yu, Y.C. Xu, Z. Chen, H. Ying
{"title":"41 (PB029): Preclinical characterization of ABSK131, a potential best-in-class MTAcooperative PRMT5 inhibitor","authors":"W. Pan, H. Wang, F. Qi, H. Deng, H. Yu, Y.C. Xu, Z. Chen, H. Ying","doi":"10.1016/j.ejca.2024.114569","DOIUrl":"10.1016/j.ejca.2024.114569","url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114569"},"PeriodicalIF":7.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信